New York City: The annual GV Impact List released on 8 March to mark International Women’s Day, pays tribute to 25 leaders who are “changing the face of technology and life sciences”.
For this year’s Impact List, GV founders and CEOs were invited to nominate a woman or non-binary team member making a difference to their company’s culture, innovation, and growth. They received a large number of “deeply impressive submissions” — twice as many as last year — from across 300+ portfolio companies. The GV committee carefully reviewed each nomination, and voted to select “top 25 powerhouses, all remarkable for the ways they inspire colleagues, foster business growth, push boundaries with integrity, and make meaningful contributions to shape the future”.
GV has stated that scientists make up nearly half of the list this year. Many of the researchers in the list lead teams to develop medicines and treatments for disease. Others are advancing computational techniques to transform the way drugs are discovered, exploring gene therapy treatments for cardiac patients, and breaking new ground in cell therapy manufacturing. One is driving for better access to women’s healthcare. And another used her biomedical research expertise to manage a study which found that O blood type may be protective against COVID-19. Against the backdrop of a grim pandemic year, more than half of the Impact List honorees have devoted their professional energies and focus toward social good.
GV was founded as Google Ventures in 2009. The Company is run as an independent, return-driven fund. Today it has more than $5 billion under management, with Alphabet as the sole limited partner.
2021 GV Impact List Honorees photo: courtesy GV website